
CGT Catapult’s creating opportunities in UK cell and gene therapy
The Cell and Gene Therapy (CGT) Catapult has today published its Annual Review 2021, highlighting its key initiatives and impact in creating opportunities and investment in the UK cell and gene therapy industry. 2021 has reportedly emphasised the strength of the UK cell and gene therapy industry which experienced… Read More















